Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy

NCT01398592 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Vildagliptin
DRUG: Sitagliptin

Sponsor

Novartis Pharmaceuticals